You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Economic Evaluation of Genomic Test–Directed Chemotherapy for Early-Stage Lymph Node–Positive Breast Cancer
|
|---|---|
| Published in |
JNCI: Journal of the National Cancer Institute, December 2011
|
| DOI | 10.1093/jnci/djr484 |
| Pubmed ID | |
| Authors |
Peter S. Hall, Christopher McCabe, Robert C. Stein, David Cameron |
| Abstract |
Multi-parameter genomic tests identify patients with early-stage breast cancer who are likely to derive little benefit from adjuvant chemotherapy. These tests can potentially spare patients the morbidity from unnecessary chemotherapy and reduce costs. However, the costs of the test must be balanced against the health benefits and cost savings produced. This economic evaluation compared genomic test-directed chemotherapy using the Oncotype DX 21-gene assay with chemotherapy for all eligible patients with lymph node-positive, estrogen receptor-positive early-stage breast cancer. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Bosnia and Herzegovina | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 2% |
| Canada | 3 | 2% |
| France | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 139 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 25 | 17% |
| Student > Master | 19 | 13% |
| Student > Ph. D. Student | 18 | 12% |
| Other | 12 | 8% |
| Student > Postgraduate | 10 | 7% |
| Other | 35 | 24% |
| Unknown | 28 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 42 | 29% |
| Economics, Econometrics and Finance | 15 | 10% |
| Nursing and Health Professions | 11 | 7% |
| Biochemistry, Genetics and Molecular Biology | 7 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Other | 31 | 21% |
| Unknown | 34 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2012.
All research outputs
#21,038,338
of 25,838,141 outputs
Outputs from JNCI: Journal of the National Cancer Institute
#7,101
of 7,890 outputs
Outputs of similar age
#206,085
of 248,335 outputs
Outputs of similar age from JNCI: Journal of the National Cancer Institute
#74
of 91 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,890 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.5. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,335 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.